WBWilliam A. Bradley

William A. Bradley

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


William A. Bradley has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Akira Tanaka

    Department of Medicine, Division of Gerontology and Geriatrics, ‡Division of Cardiovascular Disease, University of Alabama, Birmingham, AL 35294-0012; §Third Department of Internal Medicine, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan; ¶University of Tsukuba, Department of Pathology, Institute of Basic Medical Sciences, Tsukuba 305-8575, Japan; and ‖Cancer Center, University of California, San Francisco, CA 94143-0808

    1 shared publication
  • Hiroaki Shimoyamada

    Department of Medicine, Division of Gerontology and Geriatrics, ‡Division of Cardiovascular Disease, University of Alabama, Birmingham, AL 35294-0012; §Third Department of Internal Medicine, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan; ¶University of Tsukuba, Department of Pathology, Institute of Basic Medical Sciences, Tsukuba 305-8575, Japan; and ‖Cancer Center, University of California, San Francisco, CA 94143-0808

    1 shared publication
  • M. P. Ramprasad

    Department of Medicine, Division of Gerontology and Geriatrics, ‡Division of Cardiovascular Disease, University of Alabama, Birmingham, AL 35294-0012; §Third Department of Internal Medicine, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan; ¶University of Tsukuba, Department of Pathology, Institute of Basic Medical Sciences, Tsukuba 305-8575, Japan; and ‖Cancer Center, University of California, San Francisco, CA 94143-0808

    1 shared publication
  • Matthew L. Brown

    Department of Medicine, Division of Gerontology and Geriatrics, University of Alabama, Birmingham, AL 35294-0012, USA

    1 shared publication
  • Patrick K. Umeda

    Department of Medicine, Division of Gerontology and Geriatrics, ‡Division of Cardiovascular Disease, University of Alabama, Birmingham, AL 35294-0012; §Third Department of Internal Medicine, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan; ¶University of Tsukuba, Department of Pathology, Institute of Basic Medical Sciences, Tsukuba 305-8575, Japan; and ‖Cancer Center, University of California, San Francisco, CA 94143-0808

    1 shared publication
  • Ran Li

    Department of Medicine, Division of Gerontology and Geriatrics, ‡Division of Cardiovascular Disease, University of Alabama, Birmingham, AL 35294-0012; §Third Department of Internal Medicine, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan; ¶University of Tsukuba, Department of Pathology, Institute of Basic Medical Sciences, Tsukuba 305-8575, Japan; and ‖Cancer Center, University of California, San Francisco, CA 94143-0808

    1 shared publication

Latest Publications

  • A macrophage receptor for apolipoprotein B48: Cloning, expression, and atherosclerosis

    by Matthew L. Brown, M. P. Ramprasad, Patrick K. Umeda, Akira Tanaka, Yasushi Kobayashi, Teruo Watanabe, Hiroaki Shimoyamada, Wen-Lin Kuo, Ran Li, Ruiling Song, et al.

    We have cloned a human macrophage receptor that binds to apolipoprotein (apo)B48 of dietary triglyceride (TG)-rich lipoproteins. TG-rich lipoprotein uptake by the apoB48R rapidly converts macrophages and apoB48R-transfected Chinese hamster ovary cells in vitro into lipid-filled foam cells, as seen in atherosclerotic lesions. The apoB48R cDNA (3,744 bp) encodes a protein with no known homologs. Its ≈3.8-kb mRNA is expressed primarily by reticuloendothelial cells: monocytes, macrophages, and endothelial cells. Immunohistochemistry shows the apoB48R is in human atherosclerotic lesion foam cells. Normally, the apoB48R may provide essential lipids to reticuloendothelial cells. If overwhelmed, foam cell formation, endothelial dysfunction, and atherothrombogenesis may ensue, a mechanism for cardiovascular disease risk of elevated TG.